Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Sm, Straus"'
Autor:
Cm, Swaan, Marianne AB van der Sande, Speelman P, Ma, Conyn-Van Spaendonck, Sm, Straus, Ra, Coutinho
Publikováno v:
Europe PubMed Central
The influenza vaccine is considered safe, but information on vaccine-related adverse events is limited and a nationwide overview of adverse events is lacking. In 2006, after deaths occurred in Israel and the Netherlands following influenza vaccinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::88adf203611a3d7af2031a0c2bccd016
http://europepmc.org/abstract/med/17957995
http://europepmc.org/abstract/med/17957995
Autor:
Gadroen K; Department of Medical Informatics, Erasmus MC, Rotterdam, the Netherlands.; Medicines Evaluation Board (CBG-MEB), Utrecht, the Netherlands., Kemmeren JM; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Bruijning-Verhagen PC; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands., Straus SM; Department of Medical Informatics, Erasmus MC, Rotterdam, the Netherlands.; Medicines Evaluation Board (CBG-MEB), Utrecht, the Netherlands., Weibel D; Department of Medical Informatics, Erasmus MC, Rotterdam, the Netherlands., de Melker HE; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Sturkenboom MC; Department of Medical Informatics, Erasmus MC, Rotterdam, the Netherlands.
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2017 Jun 22; Vol. 22 (25).
Autor:
Pacurariu AC; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.; Dutch Medicines Evaluation Board, Utrecht, The Netherlands., Coloma PM; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands., Gross-Martirosyan L; Dutch Medicines Evaluation Board, Utrecht, The Netherlands., Sturkenboom MC; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands., Straus SM; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2017 Mar; Vol. 26 (3), pp. 327-334. Date of Electronic Publication: 2016 Nov 23.
Autor:
de Bie S; From the *Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands; †Department of Pediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, APHP; Univ Paris 7-Diderot, Sorbonne Paris Cité, EA08; INSERM CIC1426, Paris, France; ‡International Pharmaco-epidemiology and Pharmaco-economics Research Center, Desio, Italy; §Medicines Evaluations Board, Utrecht, The Netherlands; ¶Società Italiana di Medicina Generale, Florence, Italy; ‖Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands; and **Paediatric Infectious Diseases Research Group, St George's University London, London, United Kingdom., Kaguelidou F, Verhamme KM, De Ridder M, Picelli G, Straus SM, Giaquinto C, Stricker BH, Bielicki J, Sharland M, Sturkenboom MC
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2016 Dec; Vol. 35 (12), pp. 1317-1323.
Autor:
Vermeer NS; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands., Ebbers HC; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands., Straus SM; Medicines Evaluation Board, Utrecht, The Netherlands.; Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands., Leufkens HG; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands., Egberts TC; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands., De Bruin ML; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2016 Mar; Vol. 25 (3), pp. 297-306. Date of Electronic Publication: 2015 Dec 16.
Autor:
Pacurariu AC; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.; Dutch Medicines Evaluation Board, Utrecht, The Netherlands., Straus SM; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.; Dutch Medicines Evaluation Board, Utrecht, The Netherlands., Trifirò G; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy., Schuemie MJ; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands., Gini R; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Herings R; PHARMO Institute, Utrecht, The Netherlands., Mazzaglia G; Società Italiana di Medicina Generale, Florence, Italy., Picelli G; Pedianet-Società Servizi Telematici SRL, Padua, Italy., Scotti L; Department of Statistics, Università di Milano-Bicocca, Milan, Italy., Pedersen L; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark., Arlett P; European Medicines Agency, London, UK., van der Lei J; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands., Sturkenboom MC; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands., Coloma PM; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands. p.coloma@erasmusmc.nl.
Publikováno v:
Drug safety [Drug Saf] 2015 Dec; Vol. 38 (12), pp. 1201-10.
Autor:
Vermeer NS; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands., Straus SM; Medicines Evaluation Board, Utrecht, The Netherlands.; Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands., Mantel-Teeuwisse AK; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands., Hidalgo-Simon A; European Medicines Agency, London, United Kingdom., Egberts AC; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands., Leufkens HG; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands., De Bruin ML; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2015 Nov; Vol. 98 (5), pp. 542-50. Date of Electronic Publication: 2015 Sep 08.
Strategy in Regulatory Decision-Making for Management of Progressive Multifocal Leukoencephalopathy.
Autor:
Segec A; European Medicines Agency, London, United Kingdom., Keller-Stanislawski B; Department of Safety of Medicinal Products and Medical Devices, Paul-Ehrlich Institute, Federal Institute for Vaccines and Biomedicines, Langen, Germany., Vermeer NS; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands., Macchiarulo C; Agenzia Italiana del Farmaco (AIFA), Rome, Italy., Straus SM; Medicines Evaluation Board, Utrecht, The Netherlands., Hidalgo-Simon A; European Medicines Agency, London, United Kingdom., De Bruin ML; Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2015 Nov; Vol. 98 (5), pp. 502-5. Date of Electronic Publication: 2015 Sep 11.
Autor:
de Bie S; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.; Dutch Medicines Evaluation Board, Utrecht, the Netherlands., Coloma PM; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands., Ferrajolo C; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.; Campania Regional Center of Pharmacovigilance and Pharmacoepidemiology, Department of Experimental Medicine, Pharmacology Section, Second University of Naples, Naples, Italy., Verhamme KM; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands., Trifirò G; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, Messina, Italy., Schuemie MJ; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands., Straus SM; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.; Dutch Medicines Evaluation Board, Utrecht, the Netherlands., Gini R; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Herings R; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.; PHARMO Institute, Utrecht, the Netherlands., Mazzaglia G; Società Italiana di Medicina Generale, Florence, Italy., Picelli G; Pedianet-Società Servizi Telematici SRL, Padova, Italy., Ghirardi A; Department of Statistics, Universita di Milano-Bicocca, Milan, Italy., Pedersen L; Department of Clinical Epidemiology, Aarhus University Hospital Aarhus, Denmark., Stricker BH; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Inspectorate of Health Care, The Hague, the Netherlands., van der Lei J; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands., Sturkenboom MC; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2015 Aug; Vol. 80 (2), pp. 304-14. Date of Electronic Publication: 2015 May 20.
Autor:
Zomerdijk IM; Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, the Netherlands.; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands.; Dutch Medicines Evaluation Board, Utrecht, the Netherlands., Ruiter R; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands., Houweling LM; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands., Herings RM; PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands., Straus SM; Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, the Netherlands., Stricker BH; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands.; Drug Safety Unit, Inspectorate of Health Care, The Hague, the Netherlands.
Publikováno v:
BJOG : an international journal of obstetrics and gynaecology [BJOG] 2015 Jul; Vol. 122 (8), pp. 1119-29. Date of Electronic Publication: 2014 Oct 15.